| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Laxatives |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
|
ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QA08...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
Contents |
A08A Antiobesity preparations, excluding diet products
A08AA Centrally acting antiobesity products
- A08AA01 Phentermine
- A08AA02 Fenfluramine
- A08AA03 Amfepramone
- A08AA04 Dexfenfluramine
- A08AA05 Mazindol
- A08AA06 Etilamfetamine
- A08AA07 Cathine
- A08AA08 Clobenzorex
- A08AA09 Mefenorex
- A08AA10 Sibutramine
- A08AA56 Ephedrine, combinations
A08AB Peripherally acting antiobesity products
- A08AB01 Orlistat
- QA08AB90 Mitratapide
- QA08AB91 Dirlotapide
A08AX Other antiobesity drugs
- A08AX01 Rimonabant
See also
- Diet products are in the ATC group V06A.
References
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
